- The trend backdrop is active with a 5-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
HSIC
NASDAQ
Week ended 24 Jul 2026
Weekly Investor Report
Henry Schein Inc · Healthcare · Medical Distribution
Latest close
85.47 USD
-2.7%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 9.3% above the Trend Line and sits at 85.9% of its 52-week range. The latest completed week returned -2.7%, after a 0.6% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is neither clearly cheap nor expensive. Options positioning is bullish with 48/100 conviction, while the latest news-sentiment score is 54/100. Near-term considerations: volume confirmation is below normal; earnings are due in 5d.
Setup score
56
out of 100
Latest Close
85.47 USD
24 Jul 2026
1W Return
-2.7%
latest completed week
4W Return
0.6%
short-term follow-through
12W Return
15.6%
quarterly tape
Trend Breadth
48.1%
25 of 52 weeks active
Volume Ratio
0.9x
vs 13-week average
- Next-week expectancy is negative at 44.62% based on similar historical setup states.
- 4 reversal markers appear in the recent smart-money tape.
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-2.7%
Latest completed week; four-week move 0.6%.
Indicator stack
44/72
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 44.62%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
Options pressure
Bullish
48/100 conviction; expected move 8.5%.
News sentiment
54/100
47 relevant articles in the latest sentiment read.
Event risk
5d
Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 9.3% above the Trend Line and sits at 85.9% of its 52-week range. The latest completed week returned -2.7%, after a 0.6% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.9x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
30 Jan
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.6812-week average 0.45
12-week confirmation
Trend active5/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure6/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership4/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.68Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers44 reversal markers
No recent accumulation markers. 4 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 0.6% over four weeks, 15.6% over 12 weeks, and 19.6% over one year. The current trend has remained active for 5 consecutive weeks.
Performance by holding period
Active trend streak5 weeks
Active weeks in one year25
Trend breadth48.1%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.95Latest activity-pressure read.
Pressure change58.6%Four-week change in activity pressure.
Leadership5.22Latest relative-leadership reading.
RS change549.3%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is neither clearly cheap nor expensive.
Factor week 26 Jul 2026
Financial statements through 31 Dec 2025
Field coverage 94%
Model confidence 90%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength21/100Blend of value, momentum, and quality. Underlying universe rank 80; rank 1 is best.
Value28/100Relative valuation strength. Underlying universe rank 73; rank 1 is best.
Quality22/100Profitability and accounting quality. Underlying universe rank 79; rank 1 is best.
Momentum69/100Medium-term price momentum. Underlying universe rank 32; rank 1 is best.
Growth11/100Revenue and earnings growth. Underlying universe rank 90; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework41/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 24.6x Price divided by trailing earnings.
- Price / sales
- 0.7x Market value relative to trailing revenue.
- EV / EBITDA
- 14.9x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 4.9% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 29.7% Gross profit retained from each unit of revenue.
- Operating margin
- 5.2% Operating profit retained from revenue.
- Free-cash-flow margin
- 5.4% Free cash flow generated from revenue.
- Return on invested capital
- 7.7% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 5.6% Latest one-year revenue growth.
- EPS growth
- -2.9% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- -15.5% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 4/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- 5.8% Net share repurchases relative to market value.
- Shareholder yield
- 5.8% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 3.6x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Options positioningBullish
HSIC shows bullish options pressure with a 48/100 conviction score, put-call volume ratio of 0.00, expected move of 8.5%, and Sharemaestro trend signal active.
Conviction48/100
Expected move8.5%
Put/call volume0.00
Insider activity2 / 3
2 acquisitions and 3 disposals in the latest 180-day insider tape.
Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.News sentiment54/100
Weighted news tone is neutral across 47 relevant articles.
11 positive · 33 neutral · 3 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings5dNext report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
Options expected move8.5%Nearest-chain priced movement where available.
52-week drawdown-4.3%Distance below the 52-week high.
13-week volatility3.4%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
30 Jan
27 Feb
27 Mar
24 Apr
22 May
19 Jun
24 Jul
Weeks higher14 of 2612 weeks finished lower.
Best week+6.3%Week of 26 Jun.
Worst week-5.8%Week of 6 Mar.
Latest week-2.7%Week of 24 Jul.
Shape of recent returns
Strong gains5
Modest gains9
Flat weeks0
Modest losses8
Sharp losses4
Recent vol3.4%13-week weekly-return volatility.
Base vol3.5%52-week weekly-return volatility.
Up/down split26/26Count of positive and negative weeks in the 52-week window.
Average skew3.2% / -2.4%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorUS Healthcare
4-week rank- / 100
Group average1.3%
Trend breadth51.0%
Trend51.0%active weekly trend signals
MD75.0%positive activity pressure
RS48.0%positive relative leadership
Four-week leaders
IndustryUS Medical Distribution
4-week rank5 / 10
Group average0.0%
Trend breadth30.0%
Trend30.0%active weekly trend signals
MD60.0%positive activity pressure
RS20.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape55/100
Trend, activity pressure, participation, and risk combine to a 55/100 tape read.
Indicator analysis40/100Latest 12-week confirmation: trend 5/12, activity pressure 6/12, relative leadership 4/12.
Activity pressure 0.68; 4 reversal markers Next-Week ExpectancyNegative 44.62%Next-week expectancy is negative with a 44.62% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors32/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 10; Small Cap Core rank 63 SVQF41/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 431.0 of 726 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Options45/100HSIC shows bullish options pressure with a 48/100 conviction score, put-call volume ratio of 0.00, expected move of 8.5%, and Sharemaestro trend signal active.
Bullish · Call-side pressure · Expected move 8.5% Sentiment54/100Weighted news tone is neutral across 47 relevant articles.
Henry Schein Inc. stock underperforms Monday when compared to competitors Insiders2 / 32 acquisitions and 3 disposals in the latest 180-day insider tape.
Earnings5dNext report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 24 Jul 2026 | 85.47 USD | -2.7% | 78.21 USD | 72.63 USD | 0.95 | 5.22 | 6.3M | On |
| 17 Jul 2026 | 87.82 USD | 4.1% | 77.89 USD | 72.60 USD | 1.07 | 6.36 | 6.6M | On |
| 10 Jul 2026 | 84.40 USD | -2.3% | 77.55 USD | 72.55 USD | 0.94 | -2.00 | 6.1M | On |
| 3 Jul 2026 | 86.43 USD | 1.7% | 77.28 USD | 72.52 USD | 0.92 | 1.91 | 5.7M | On |
| 26 Jun 2026 | 84.95 USD | 6.3% | 76.86 USD | 72.47 USD | 0.60 | 0.80 | 6.9M | On |
| 19 Jun 2026 | 79.92 USD | -1.6% | 76.51 USD | 72.45 USD | 0.21 | -9.63 | 5.0M | Off |
| 12 Jun 2026 | 81.25 USD | 4.9% | 76.29 USD | 72.44 USD | -0.12 | -6.12 | 7.7M | Off |
| 5 Jun 2026 | 77.45 USD | 1.1% | 75.97 USD | 72.42 USD | -0.48 | -8.75 | 6.7M | Off |
| 29 May 2026 | 76.58 USD | 3.2% | 75.78 USD | 72.40 USD | -0.60 | -14.16 | 6.5M | Off |
| 22 May 2026 | 74.21 USD | 2.0% | 75.33 USD | 72.39 USD | -0.67 | -14.84 | 6.2M | Off |
| 15 May 2026 | 72.72 USD | 2.7% | 74.99 USD | 72.39 USD | -0.60 | -16.04 | 11.3M | Off |
| 8 May 2026 | 70.82 USD | -4.2% | 74.66 USD | 72.42 USD | -0.55 | -18.95 | 11.8M | Off |
| 1 May 2026 | 73.93 USD | -4.7% | 74.41 USD | 72.46 USD | -0.58 | -11.32 | 6.7M | On |
| 24 Apr 2026 | 77.54 USD | -1.6% | 74.18 USD | 72.49 USD | -0.65 | -5.91 | 5.3M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.